These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 11355955

  • 1. MDR1 causes resistance to the antitumour drug miltefosine.
    Rybczynska M, Liu R, Lu P, Sharom FJ, Steinfels E, Pietro AD, Spitaler M, Grunicke H, Hofmann J.
    Br J Cancer; 2001 May 18; 84(10):1405-11. PubMed ID: 11355955
    [Abstract] [Full Text] [Related]

  • 2. Gene-specific DNA repair and steady state transcription of the MDR1 gene in human tumor cell lines.
    Evans MK, Chin KV, Gottesman MM, Bohr VA.
    Oncogene; 1996 Feb 01; 12(3):651-8. PubMed ID: 8637722
    [Abstract] [Full Text] [Related]

  • 3. Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein.
    Abulrob AG, Gumbleton M.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):121-6. PubMed ID: 10448079
    [Abstract] [Full Text] [Related]

  • 4. Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
    Robey RW, Zhan Z, Piekarz RL, Kayastha GL, Fojo T, Bates SE.
    Clin Cancer Res; 2006 Mar 01; 12(5):1547-55. PubMed ID: 16533780
    [Abstract] [Full Text] [Related]

  • 5. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells.
    Gao Z, Gao Z, Fields JZ, Boman BM.
    Anticancer Res; 1998 Mar 01; 18(4C):3073-6. PubMed ID: 9713512
    [Abstract] [Full Text] [Related]

  • 6. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
    Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S.
    Pharm Res; 2006 Jul 01; 23(7):1460-72. PubMed ID: 16779700
    [Abstract] [Full Text] [Related]

  • 7. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra.
    Cao J, Chen X, Liang J, Yu XQ, Xu AL, Chan E, Wei D, Huang M, Wen JY, Yu XY, Li XT, Sheu FS, Zhou SF.
    Drug Metab Dispos; 2007 Apr 01; 35(4):539-53. PubMed ID: 17220245
    [Abstract] [Full Text] [Related]

  • 8. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA, Tsvetaeva DA, Grudinskaja TV.
    Exp Oncol; 2013 Dec 01; 35(4):287-90. PubMed ID: 24382439
    [Abstract] [Full Text] [Related]

  • 9. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
    Luker GD, Rao VV, Crankshaw CL, Dahlheimer J, Piwnica-Worms D.
    Biochemistry; 1997 Nov 18; 36(46):14218-27. PubMed ID: 9369495
    [Abstract] [Full Text] [Related]

  • 10. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
    Moretti JL, Duran Cordobes M, Starzec A, de Beco V, Vergote J, Benazzouz F, Boissier B, Cohen H, Safi N, Piperno-Neumann S, Kouyoumdjian JC.
    J Nucl Med; 1998 Jul 18; 39(7):1214-8. PubMed ID: 9669397
    [Abstract] [Full Text] [Related]

  • 11. Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities.
    Rybczynska M, Spitaler M, Knebel NG, Boeck G, Grunicke H, Hofmann J.
    Biochem Pharmacol; 2001 Sep 15; 62(6):765-72. PubMed ID: 11551522
    [Abstract] [Full Text] [Related]

  • 12. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
    Ernest S, Bello-Reuss E.
    Am J Physiol; 1996 Mar 15; 270(3 Pt 1):C910-9. PubMed ID: 8638674
    [Abstract] [Full Text] [Related]

  • 13. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM, Usta M, van der Velde AE, Boersma MG, Spenkelink B, van Zanden JJ, Rietjens IM, van Bladeren PJ, Cnubben NH.
    Chem Res Toxicol; 2003 Dec 15; 16(12):1642-51. PubMed ID: 14680379
    [Abstract] [Full Text] [Related]

  • 14. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, Stoter G, Nooter K.
    Clin Cancer Res; 2003 Feb 15; 9(2):827-36. PubMed ID: 12576456
    [Abstract] [Full Text] [Related]

  • 15. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ, Broxterman HJ, Ossenkoppele GJ, Baak JP, Eekman CA, Kuiper CM, Feller N, van Heijningen TH, Klumper E, Pieters R.
    Clin Cancer Res; 1995 Jan 15; 1(1):81-93. PubMed ID: 9815890
    [Abstract] [Full Text] [Related]

  • 16. Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins.
    Kino K, Taguchi Y, Yamada K, Komano T, Ueda K.
    FEBS Lett; 1996 Dec 09; 399(1-2):29-32. PubMed ID: 8980113
    [Abstract] [Full Text] [Related]

  • 17. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
    Utz I, Gekeler V, Ise W, Beck J, Spitaler M, Grunicke H, Hofmann J.
    Anticancer Res; 1996 Dec 09; 16(1):289-96. PubMed ID: 8615623
    [Abstract] [Full Text] [Related]

  • 18. Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979.
    Shepard RL, Cao J, Starling JJ, Dantzig AH.
    Int J Cancer; 2003 Jan 01; 103(1):121-5. PubMed ID: 12455064
    [Abstract] [Full Text] [Related]

  • 19. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
    Sakata S, Fujiwara M, Ohtsuka K, Kamma H, Nagane M, Sakamoto A, Fujioka Y.
    Oncol Rep; 2011 Feb 01; 25(2):333-9. PubMed ID: 21165575
    [Abstract] [Full Text] [Related]

  • 20. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D, Eriksen J, Maare C, Friche E, Skovsgaard T.
    Cancer Chemother Pharmacol; 2002 Jun 01; 49(6):453-60. PubMed ID: 12107549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.